Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab

MeSH terms

• Aged, 80 and over
• Antibodies, Monoclonal, Murine-Derived / administration & dosage
• Antibodies, Monoclonal, Murine-Derived / therapeutic use*
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use*
• B-Lymphocytes / drug effects
• B-Lymphocytes / virology*
• Drug Administration Schedule
• Herpesvirus 4, Human / genetics
• Herpesvirus 4, Human / isolation & purification*
• Humans
• In Situ Hybridization
• Lymphoproliferative Disorders / complications
• Lymphoproliferative Disorders / diagnosis*
• Lymphoproliferative Disorders / drug therapy*
• Lymphoproliferative Disorders / etiology
• Lymphoproliferative Disorders / immunology
• Lymphoproliferative Disorders / virology
• Male
• Organ Transplantation / adverse effects
• RNA, Viral / isolation & purification
• Respiration Disorders / etiology
• Rituximab
• Tongue / pathology*
• Tongue / virology*